Labetalol vs.Nicardipine for Hypertension in Patients with Acute Aortic Dissection

LU Lixiong,ZHU Changqing,ZHANG Xingyu,CHEN Yi,LIN Maoyun
DOI: https://doi.org/10.3969/j.issn.1001-0408.2007.20.022
2007-01-01
Abstract:OBJECTIVE:To evaluate the efficacy and safety of intravenous labetalol or intravenous nicardipine for hypertension associated with aortic dissection.METHODS:A total of 60 patients with aortic dissection-related hypertension were randomly assigned to receive intravenous labetalol or nicardipine.RESULTS:Treatment response(10%~15% decrease in mean arterial pressure in 10 minutes treatment) was achieved in 38% of labetalol-treated patients and in 45% of nicardipine-treated group(P>0.05).After 30 minutes treatment,93% patients in labetalol group reached goal blood pressure(<120/80mmHg),compared with 90% in nicardipine group(P>0.05).However,tachycardia was significantly(P<0.05) more frequent in nicardipine group((83±10)beats per minute) than in labetalol group((77±7)beats per minute).CONCLUSION:Both labetalol and nicardipine can effectively keep the blood pressure under control in patients with acute aortic dissection.However,intravenous labetalol alone is more suitable than intravenous nicardipine alone in this clinical emergency case.
What problem does this paper attempt to address?